Regenerative Medicine for Parkinson’s Disease, is an alternative option to help manage symptoms.
Whether you have recently been diagnosed or battling this condition for years, this breakthrough in Regenerative Medicine may be a potential opportunity for an alternative option in your journey to wellness.
With Regenerative Medicine for Parkinson’s Disease, you have an option for a new rebuilding process.
Studies have shown the following potential symptom improvements:
Discover our wide range of treatments by calling us at (800) 531-0831
Parkinson’s Disease is a progressive nervous system condition in which a person’s movement is affected by nerve cell damage in the brain. Specifically, the nerve cells which produce the neurotransmitter dopamine become affected in Parkinson’s Disease. Dopamine plays an essential role in regulating messages that support muscle coordination and movement. In patients with Parkinson’s, 60% to 80% of dopamine-producing cells are damaged.
While there is currently no cure for Parkinson’s Disease, it is possible for patients to maintain a rich quality of life with the help of various medical interventions. Medications, herbal therapies, and supplements can be used to help control symptoms, but there are also other therapies Parkinson’s Disease patients may wish to explore. This is especially true since recent neuroscience research suggests
Parkinson’s Disease isn’t just a result of the loss of dopamine; there are other systems that contribute to brain signals which are also suspected to contribute to disease progression. In particular, serotonin loss appears to be a factor in the condition and continues even after patients are treated with dopamine-enhancing therapies.
Regenerative Medicine for Parkinson’s disease targets the underlying cellular damage. Researchers have explored various sources of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells, such as mesenchymal stem cells (MSCs). These cells possess the remarkable ability to differentiate into various cell types, including dopamine-producing neurons.
Transplantation of stem cell-derived dopamine neurons into the brains of Parkinson’s patients has shown promising results in preclinical and early clinical trials of stem cell treatment for Parkinson’s. These transplanted cells can potentially integrate into the existing neural circuitry, restore dopamine production, and improve motor symptoms. However, challenges such as immune rejection, ethical considerations, and refining the transplantation techniques still need to be addressed before widespread implementation.
Regenerative Medicine for Parkinson’s disease has shown potential as a beneficial treatment for Parkinson’s Disease by addressing the replacement and repair of damaged nerve cells responsible for producing dopamine in the brain. A notable study published in the journal “Stem Cells Translational Medicine” in 2016 shed light on the outcomes of phase I clinical trial involving 12 Parkinson’s disease patients who received transplants of mesenchymal stem cells (MSCs) derived from bone marrow.
In this prospective, uncontrolled, pilot study, participants with a mean disease duration of 14.7 ± 7.56 years were enrolled. They underwent a single-dose, unilateral transplantation of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs). The patients were closely monitored for a follow-up period of 36 months after the transplant, allowing for observation of the longer-term effects.
The study demonstrated that the transplantation procedure was safe, and the patients experienced improvements in their motor function along with a reduction in the severity of their Parkinson’s disease symptoms.
Regenerative medicine encompasses a broader spectrum of therapies beyond regenerative medicine for Parkinson’s alone. Scientists are exploring innovative techniques to stimulate the body’s own regenerative capacity, aiming to repair and replace damaged neurons for regenerative medicine for Parkinson’s patients.
One approach involves utilizing growth factors, small molecules, or gene therapy to activate dormant stem cells within the brain, promoting their differentiation into dopamine-producing neurons. This method could potentially bypass the need for external stem cell transplantation, providing a more sustainable and patient-specific therapeutic approach.
For neurodegenerative disorders like Parkinson’s Disease, regenerative biological products could be an option for managing symptoms of chronic conditions. These therapies can encompass the use of regenerative biological products, which have the potential to replace many different cell types, including those in the brain which become compromised by neurodegenerative disorders.
Delivering regenerative medicine therapy for Parkinson’s Disease through targeted areas has been researched in studies of preventing the increase of inflammatory cells which contribute to chronic conditions as well as the depletion of dopamine. Moreover, beyond restoring dopamine and minimizing inflammation, regenerative medicine may also aid in serotonin neuron regeneration.
Emerging Regenerative Medicine therapy studies show potential in helping patients maintain a more comfortable quality of life.
Regenerative Medicine is still considered an experimental procedure and not approved by the FDA. Patients must consider realistic expectations in their research and possible therapy options. To learn more about regenerative medicine for Parkinson’s contact us now!
Discover our wide range of treatments by calling us at (800) 531-0831
Speak with a Care Coordinator today for a more accurate assessment of your condition and therapy options.
Watch Annamarie’s heart-touching story about her experience battling Parkinson’s Disease and how she’s been relieved of her symptoms and become medication free post-treatment!
Our Board-Certified Physicians specialize in regenerative medicine. They stay abreast of the latest developments in regenerative medicine research. Each patient is screened and reviewed before being approved for therapy.
Each patient is thoroughly reviewed to ensure their safety for treatment. The physicians will then determine potential benefit candidacy. If approved, a customized treatment plan is offered for the patient.
Stemedix can help coordinate patients with necessary wheelchair transportation, medical equipment, and Care Giving services as needed during their stay. Your Care Coordinator is available for questions and assistance.
Autoimmune and autoinflammatory diseases are driven by complex changes in immune regulation. Standard treatments can reduce disease activity, but many conditions remain difficult to control and may require long-term immunosuppression. A peer-reviewed review published in Frontiers in Immunology examines how mesenchymal stem/stromal cells (MSCs) interact with the immune system and why they are being studied…
Much of the initial excitement surrounding stem cells was that they have the potential to become other types of cells. Add cardiac stem cells to a heart damaged by a heart attack, for example, and perhaps those stem cells will become new heart cells and restore heart function. While this does occur—stem cells differentiated mature…
Umbilical Cord-Derived Stem Cells Could Help with Primary Biliary Cirrhosis Posted June 11, 2018 and filed under Stem Cell Research. Researchers have recently published their results from an experiment conducted to determine if a certain type of stem cell, called the umbilical cord-derived mesenchymal stem cell, has the potential for treating primary biliary cirrhosis. Primary…
Contact us today and let Stemedix provide a professional service accompanied by one of our Care Coordinators to ensure you have the best experience possible!